All News

2070 articles, sorted by publication time.

Industry · global

The Industrial Paradox of India’s Genome Valley: High Pharma Output, Thin Local Returns

The life sciences cluster around Hyderabad supports India’s vast pharmaceutical production capacity and carries the image of a “pharma capital.” But when output figures are disproportionate to employment, fiscal returns, and local innovation gains, the issue is not only investment promotion results, but how a biopharma park turns scale into public value.

Biopharmaceuticals · global

Sino Biopharmaceutical and GSK Join Hands Again, Extending Their Respiratory Drug Footprint Into the Chinese Market

An expansion of a licensing partnership reflects a renewed adjustment in the division of roles between multinational drugmakers and Chinese domestic companies in the respiratory disease market; but with limited public information available, the clinical and commercial significance of the transaction can still only be interpreted cautiously.

Biopharma · global

Graft-Versus-Host Disease Drug Landscape Heats Up, but Immune Reconstitution Remains the Core Challenge

A new industry report has brought several pharmaceutical companies’ graft-versus-host disease pipelines back into focus; the real question is not only whether the number of candidate drugs is increasing, but whether a more precise balance can be found between suppressing immune attack and preserving anti-infection and relapse-prevention capacity.